OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Supplements and Featured Publications

home / publications / supplements
  • All
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • All
  • Breast Cancer
  • CAR T-cell Therapy
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Precision Medicine in Oncology®
  • Sarcomas
Unpacking Pivotal Data Updates in Metastatic Breast Cancer Management

Unpacking Pivotal Data Updates in Metastatic Breast Cancer Management

Volume: 1

Issue: 1

View Issue
Focus on Pathways: SERMS in Metastatic Breast Cancer

Focus on Pathways: SERMS in Metastatic Breast Cancer

View Issue
Top 2021 Abstracts in Breast Cancer

Top 8 Trials From 2021 in Breast Cancer

Volume: 01

Issue: 01

View Issue
SABCS 2021: Updates in HER2+ Breast Cancer

SABCS 2021: Updates in HER2+ Breast Cancer

Volume: 01

Issue: 01

View Issue
2021 Year in Review: HER2+ Breast Cancer

2021 Year in Review: HER2+ Breast Cancer

Volume: 1

Issue: 1

View Issue
2021 ESMO Congress

2021 ESMO Congress: Breast Cancer

Volume: 1

Issue: 1

View Issue
Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer

Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer

Volume: 01

Issue: 01

View Issue
Updates in ESR1-Mutant Breast Cancer

Updates in ESR1-Mutant Breast Cancer

Volume: 1

Issue: 1

View Issue
The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer

The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer

Volume: 1

Issue: 1

View Issue
Considerations for the Management of Interstitial Lung Disease With Novel Treatments in HER2+ Breast Cancer, Lung Cancers, and Gastrointestinal Cancers

Considerations for the Management of Interstitial Lung Disease With Novel Treatments in HER2+ Breast Cancer, Lung Cancers, and Gastrointestinal Cancers

Volume: 1

Issue: 1

View Issue

Latest Conference Coverage

Post Hoc Analysis Shows Imetelstat Drives Benefit in RS-Negative, Lower-Risk MDS

Bexobrutideg Is Tolerable and Yields High Response Rates in Relapsed/Refractory Waldenström Macroglobulinemia

Axi-Cel, Liso-Cel, and Tisa-Cel Show Comparable Real-World Survival Outcomes in DLBCL

Pirtobrutinib Improves Patient-Reported Outcomes in Relapsed/Refractory CLL/SLL

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact